A service of StreetInsider.com
Welcome

Most Popular

AAPL 140.02
C 26.20
GOOG 408.49
BAC 27.40
RIMM 69.71

Recently Added

SLAT 0.67
LNT 25.80
NDN 26.28
HTD 10.23
AGCO 29.88

Gaining Speed

XYNH 0.01
SAPE 6.13
ACCP 2.20
SNRY 0.57
CSG 45.46
14.80 -0.39 (-2.62%) THRX

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:14.80 Change:-0.39 (-2.62%) Prev Close:15.19 Open: 14.88 Days Range:14.75 – 15.30 52 Week Range: 4.32 - 18.56 Volume:219648 P/E: N/A
EPS:-1.35

Member Comments

No member comments available for THRX


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 07/03/09

Recent Alert on 05/07/09 at 9:20am
Soleil Securities Initiates Coverage on Theravance (THRX) with a Hold

Soleil Securities initiates coverage on Theravance (Nasdaq: THRX) with a Hold. Price target $17. Soleil analyst says, "Initiate coverage with a Hold. Discovers and develops small molecule drugs, leaving commercialization to a partner. The shares... Read More

Recent Alert on 04/22/09 at 4:29pm
Theravance (THRX) Reports Better-Than-Expected Q1 Loss of $0.31
Recent Alert on 04/06/09 at 5:18pm
FDA Accepts NDA for Theravance's (THRX) Telavancin
Recent Alert on 04/06/09 at 5:18pm
Theravance (THRX) Receives FDA Acceptance of Telavancin NDA
Recent Alert on 04/06/09 at 5:18pm
Theravance (THRX) Receives FDA Acceptance of Telavancin NDA

View AllRecent Press Releases

Press Release on 07/01/09 at 8:30pm
Theravance Announces New Employment Inducement Awards

View AllRecent SEC Filings

No Recent SEC Filings Available

View AllRecent Blog Posts

Blog Posts on 06/16/09 at 3:37pm
2009 Looking Good for Theravance
Blog Posts on 06/16/09 at 5:50am
FDA Calendar: 18 Hot Summer Trades
Blog Posts on 06/01/09 at 9:40am
Klarman's Baupost Group Bets Big on Capitalsource, News Corp.
Blog Posts on 04/26/09 at 1:26am
FDA, Clinical Trial Updates: Pro-Pharma Looks Promising
Blog Posts on 04/24/09 at 3:29pm
Theravance Narrows Its Losses